Runt-related transcription factors regulate many developmental processes such as proliferation and differentiation. In this study, the function of the runt-related transcription factor 1 (RUNX1) was investigated in head and neck squamous cell carcinoma (HNSCC). Our results show that RUNX1 expression was elevated in HNSCC patients, which was greatly correlated with the N stage, tumor size, and American Joint Committee on Cancer stage. Cox proportional hazard models showed that RUNX1 could be used as a prognostic indicator for the overall survival of HNSCC patients (hazard ratio, 5.572; 95% confidence interval, 1.860–9.963; P <0.001). Moreover, suppression of RUNX1 inhibited HNSCC cell proliferation, migration, and invasion. Using the HNSCC xenograft nude mouse model, we found that the shRUNX1-transfected tumor (sh-RUNX1) was significantly smaller both in size and weight than the control vector-transfected tumor (sh-Control). In conclusion, our results show that the elevated RUNX1 expression was correlated with tumor growth and metastasis in HNSCC, indicating that RUNX1 could be used as a biomarker for tumor recurrence and prognosis.
SiegelRLMillerKDJemalA.Cancer statistics, 2020. CA Cancer J Clin2020;
70:7–30
2.
SatoHTsukaharaKOkamotoIKatsubeYShimizuAKondoTHanyuKFushimiCOkadaTMiuraK.Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients. Acta Otolaryngol2019;
22:1–5
3.
ChuangLSItoKItoY.RUNX family: regulation and diversification of roles through interacting proteins. Int J Cancer2013;
132:1260–71
4.
DeltchevaENimmoR.RUNX transcription factors at the interface of stem cells and cancer. Biochem J2017;
474:1755–68
5.
IchikawaMYoshimiANakagawaMNishimotoNWatanabe-OkochiNKurokawaM.A role for RUNX1 in hematopoiesis and myeloid leukemia. Int J Hematol2013;
97:726–34
6.
MakiKSasakiKSugitaFNakamuraYMitaniK.Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera. Int J Hematol2012;
96:268–73
7.
BoothCAGBarkasNNeoWHBoukarabilaHSoilleuxEJGiotopoulosGFarnoudNGiustacchiniAAshleyNCarrelhaJJamiesonLAtkinsonDBouriez-JonesTPrinjhaRKMilneTATeacheyDTPapaemmanuilEHuntlyBJPJacobsenSEWMeadAJ.Ezh2 and Runx1 mutations collaborate to initiate Lympho-Myeloid leukemia in early thymic progenitors. Cancer Cell2018;
33:274–91
8.
HuangXPengJWSpeckNABushwellerJH.Solution structure of core binding factor beta and map of the CBF alpha binding site. Nat Struct Biol1999;
6:624–7
9.
WongWFKohuKChibaTSatoTSatakeM.Interplay of transcription factors in T-cell differentiation and function: the role of Runx. Immunology2011;
132:157–64
10.
WangLSunYMengLXuX.First case of AML with rare chromosome translocations: a case report of twins. BMC Cancer2018;
18:458
11.
YamatoGShibaNYoshidaKHaraYShiraishiYOhkiKOkuboJParkMJSotomatsuMArakawaHKiyokawaNTomizawaDAdachiSTagaTHoribeKMiyanoSOgawaSHayashiY.RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis. Blood2018;
131:2266–70
12.
ChenKSLimJWCRichardsLJBuntJ.The convergent roles of the nuclear factor I transcription factors in development and cancer. Cancer Lett2017;
410:124–38
13.
KeitaMBachvarovaMMorinCPlanteMGregoireJRenaudMCSebastianelliATrinhXBBachvarovD.The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion. Cell Cycle2013;
12:972–86
14.
TengHWangPXueYLiuXMaJCaiHXiZLiZLiuY.Role of HCP5-miR-139-RUNX1 feedback loop in regulating malignant behavior of glioma cells. Mol Ther2016;
24:1806–22
15.
ChenYZhangLLiuLSunSZhaoXWangYZhangYDuJGuL.Rasip1 is a RUNX1 target gene and promotes migration of NSCLC cells. Cancer Manag Res2018;
10:4537–52
16.
GinosMAPageGPMichalowiczBSPatelKJVolkerSEPambuccianSEOndreyFGAdamsGLGaffneyPM.Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res2004;
64:55–63
17.
KoeppenKStantonBAHamptonTH.ScanGEO: parallel mining of high-throughput gene expression data. Bioinformatics2017;
33:3500–1
18.
SiegelRLMillerKDJemalA.Cancer statistics, 2017. CA Cancer J Clin2017;
67:7–30
19.
QiuYLLiuYHBanJDWangWJHanMKongPLiBH.Pathway analysis of a genomewide association study on a long noncoding RNA expression profile in oral squamous cell carcinoma. Oncol Rep2019;
41:895–907
20.
PolyakKWeinbergRA.Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer2009;
9:265–73
21.
HanahanDWeinbergRA.Hallmarks of cancer: the next generation. Cell2011;
144:646–74
22.
SchmalhoferOBrabletzSBrabletzT.E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev2009;
28:151–66
23.
LatchmanDS.Transcription factors: an overview. Int J Biochem Cell Biol1997;
29:1305–12
24.
TaubeJHHerschkowitzJIKomurovKZhouAYGuptaSYangJHartwellKOnderTTGuptaPBEvansKWHollierBGRamPTLanderESRosenJMWeinbergRAManiSA.Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A2010;
107:15449–54
MicolJBDuployezNBoisselNPetitAGeffroySNibourelOLacombeCLapillonneHEtancelinPFigeacMRennevilleACastaigneSLevergerGIfrahNDombretHPreudhommeCAbdel-WahabOJourdanE.Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations. Blood2014;
124:1445–9
27.
Otalora-OtaloraBAHenriquezBLopez-KleineLRojasA.RUNX family: oncogenes or tumor suppressors (Review). Oncol Rep2019;
42:3–19
28.
LiHZhaoXYanXJessenWJKimMODombiELiuPPHuangGWuJ.Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. Oncogene2016;
35:1468–74
29.
WangXZhaoYQianHHuangJCuiFMaoZ.The miR-101/RUNX1 feedback regulatory loop modulates chemo-sensitivity and invasion in human lung cancer. Int J Clin Exp Med2015;
8:15030–42
30.
ScheitzCJLeeTSMcDermittDJTumbarT.Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer. EMBO J2012;
31:4124–39
31.
ZhouYZhangXZhangJFangJGeZLiX.LRG1 promotes proliferation and inhibits apoptosis in colorectal cancer cells via RUNX1 activation. PLoS One2017;
12:e0175122 [10.1371/journal.pone.0175122]
32.
AroKKaczor-UrbanowiczKCarreras-PresasCM.Salivaomics in oral cancer. Curr Opin Otolaryngol Head Neck Surg2019;
27:91–7
33.
Kaczor-UrbanowiczKETrivediHMLimaPOCamargoPMGiannobileWVGroganTRGleber-NettoFOWhitemanYLiFLeeHJDhariaKAroKMartin Carreras-PresasCAmuthanSVartakMAkinDAl-AdbullahHBembeyKKlokkevoldPRElashoffDBarnesVMRichterRDeVizioWMastersJGWongDTW.Salivary exRNA biomarkers to detect gingivitis and monitor disease regression. J Clin Periodontol2018;
45:806–17
34.
PepeMSFengZJanesHBossuytPMPotterJD.Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst2008;
100:1432–8
